Conference
Dynamic angiogenic switch as predictor of response to chemotherapy+ bevacizumab in patients with metastatic colorectal cancer.
Authors
Cubillo A; Alvarez-Gallego R; Munoz M; Pond GR; Sanchez G; Martin M; Rodriguez-Pascual J; Garralda E; Vega E; Toledo R
Volume
34
Pagination
pp. e15126-e15126
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2016
DOI
10.1200/jco.2016.34.15_suppl.e15126
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X